Journal
DEMENTIA AND GERIATRIC COGNITIVE DISORDERS
Volume 28, Issue 1, Pages 70-74Publisher
KARGER
DOI: 10.1159/000230877
Keywords
Blood pressure; Alzheimer's disease; Longitudinal study
Categories
Funding
- Charles Wolfson Charitable Trust,
- Alzheimer's Research Trust
- Merck Co Inc.
- Oxford Comprehensive Biomedical Research Centre funding from the Department of Health's NIHR Biomedical Research Centres funding scheme, UK
- Department of Health and Human Services, Tasmania, Australia
Ask authors/readers for more resources
Background/Aims: Studies on the relation between blood pressure (BP), dementia and Alzheimer's disease (AD) have yielded inconsistent results, showing an association with high or low BP, or no association with BP. The study was designed to look at the longitudinal effect of BP on cognitive function. Methods: Participants were part of the OPTIMA longitudinal study of patients with dementia and age-matched cognitively healthy controls. The Cambridge Cognitive Examination (CAMCOG) and BP were measured. We tested the dependence of CAMCOG scores on BP using generalised linear mixed models. Results: A total of 235 were cognitively healthy controls, 42 had mild cognitive impairment (MCI), 141 had AD, and 59 had other dementia syndrome (ODS). In AD patients, the rate of decline of CAMCOG scores showed an inverted U-shaped (non-linear) dependence on diastolic BP. High (110 mm Hg) and low (60 mm Hg) levels of diastolic BP were related to faster cognitive decline over 5 years of follow-up (z = -2.51, p = 0.012). CAMCOG scores also showed an inverted U-shaped dependence on pulse pressure (z = -2.29, p = 0.022). Conclusion: High and low BP levels are related to faster cognitive decline in AD patients. This could have implications for the prevention and treatment of AD. Copyright (c) 2009 S. Karger AG, Basel
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available